Literature DB >> 26674825

The prognostic value of ABO blood group in cancer patients.

Massimo Franchini1, Giancarlo M Liumbruno2, Giuseppe Lippi3.   

Abstract

The antigens of the ABO system are expressed on red blood cell membranes as well as on the surface of several other normal and pathological cells and tissues. Following the first clinical observations more than 60 years ago, the role of ABO blood group in cancer biology has been intensely studied by several investigators, and it is now widely recognised that ABO antigens are associated with the risk of developing several types of tumours, namely pancreatic and gastric cancers. However, whether this association also affects the clinical outcome of cancer patients is less certain. In this narrative review, based on literature data, we discuss the role of ABO blood types as prognostic biomarkers in different types of cancers. The current knowledge of the underlying pathogenic mechanisms of the association is also analysed.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26674825      PMCID： PMC5016303          DOI： 10.2450/2015.0164-15

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


  76 in total

Review 1.  Soluble intercellular adhesion molecule-1 (sICAM-1): an overview.

Authors:  Anna Maria Witkowska; Maria Halina Borawska
Journal:  Eur Cytokine Netw       Date:  2004 Apr-Jun       Impact factor: 2.737

2.  Are laryngeal squamous cell carcinoma incidence and patient mortality a function of ABO blood grouping? A retrospective study.

Authors:  S I Adam; K M Wilson; S M Overholser; E Khabbaz; K Moreno; Y J Patil
Journal:  J Laryngol Otol       Date:  2011-10-10       Impact factor: 1.469

3.  Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort.

Authors:  Chunwoo Lee; Dalsan You; Mooyoung Sohn; In Gab Jeong; Cheryn Song; Taekmin Kwon; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-17       Impact factor: 4.553

Review 4.  The histo-blood group ABO system and tissue transplantation.

Authors:  T Eastlund
Journal:  Transfusion       Date:  1998-10       Impact factor: 3.157

Review 5.  Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.

Authors:  S Hakomori
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

6.  Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.

Authors:  S L Graziano; A H Tatum; N J Gonchoroff; N B Newman; L J Kohman
Journal:  Clin Cancer Res       Date:  1997-01       Impact factor: 12.531

7.  Blood group as a prognostic indicator in breast cancer.

Authors:  P J Holdsworth; J Thorogood; E A Benson; A D Clayden
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

8.  Prognostic value of ABO blood group in southern Chinese patients with established nasopharyngeal carcinoma.

Authors:  P-Y Ouyang; Z Su; Y-P Mao; Q Liu; F-Y Xie
Journal:  Br J Cancer       Date:  2013-09-10       Impact factor: 7.640

9.  Are risk factors associated with outcomes in pancreatic cancer?

Authors:  De-shen Wang; Zhi-qiang Wang; Le Zhang; Miao-zhen Qiu; Hui-yan Luo; Chao Ren; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

10.  Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women.

Authors:  Guillaume Paré; Daniel I Chasman; Mark Kellogg; Robert Y L Zee; Nader Rifai; Sunita Badola; Joseph P Miletich; Paul M Ridker
Journal:  PLoS Genet       Date:  2008-07-04       Impact factor: 5.917
View more
  16 in total

1.  ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Albertas Ulys; Dalia Žaliūnienė; Daiva Stanislovaitienė; Ramunė Šepetienė; Anželika Slavinska; Kęstutis Sužiedėlis; Vita Lesauskaitė
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

2.  Acute coronary syndrome: many doubts, some answers.

Authors:  Giuseppe Lippi; Gianfranco Cervellin
Journal:  Ann Transl Med       Date:  2016-05

3.  O blood type is a risk factor for upper gastrointestinal bleeding.

Authors:  Massimo Franchini; Thomas Togliani; Rosalia Turdo; Giuseppe Lucchini; Carlo Bonfanti; Ivano Giacomini; Mario Luppi; Stefano Pilati
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

4.  The ABO Blood Group Impacts the Survival of Patients Undergoing Pancreatoduodenectomy for Biliary Tract Cancer.

Authors:  Shozo Mori; Taku Aoki; Kazuma Tago; Takayuki Shimizu; Nobuhiro Harada; Kyung-Hwa Park; Yuhki Sakuraoka; Takayuki Shiraki; Yukihiro Iso; Keiichi Kubota
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

5.  Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany.

Authors:  Georgios Gitas; Louisa Proppe; Ibrahim Alkatout; Dimitrios Tsolakidis; Achim Rody; Christos Kotanidis; Sascha Baum
Journal:  Blood Transfus       Date:  2020-06-04       Impact factor: 3.443

6.  Blood type, ABO genetic variants, and ovarian cancer survival.

Authors:  Gabriella D Cozzi; Rebecca T Levinson; Hilary Toole; Malcolm-Robert Snyder; Angie Deng; Marta A Crispens; Dineo Khabele; Alicia Beeghly-Fadiel
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  The Probable Association between Blood Groups and Prognosis of COVID-19.

Authors:  Maryam Nasiri; Javad Khodadadi; Zahra Hajrezaei; Negar Bizhani
Journal:  Iran J Public Health       Date:  2021-04       Impact factor: 1.429

8.  Radiation-induced nausea and vomiting: Is ABO blood group as important as radiation and patient-related factors? An observational study.

Authors:  Mohsen Habibi; Amir Namimoghadam; Roghaye Korouni; Paria Fashiri; Sajad Borzoueisileh; Farideh Elahimanesh; Fatemeh Amiri; Ghobad Moradi
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 9.  Systematic review of pancreatic cancer epidemiology in Asia-Pacific Region: major patterns in GLOBACON 2012.

Authors:  Mohamad Amin Pourhoseingholi; Sara Ashtari; Nastaran Hajizadeh; Zeinab Fazeli; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

10.  ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.

Authors:  Shuang-Shuang Li; Cong-Ya Zhou; Rong Liao; Lai Xiong; Ning-Na Weng; Ya-Qin Zhao; Clifford Mason; Hong-Feng Gou; Cheng Yi; Qing Zhu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.